To describe treatment patterns of in-patient anti-spasticity medication use following traumatic spinal cord injury (SCI) in acute and rehabilitation hospital settings in British Columbia, Canada. In ...

Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...

To describe the prevalence and stability of self-reported spasticity severity in adults with chronic spinal cord injury (SCI) over a 3-year timeframe and examine predictors of severity and change in ...

Managing spasticity involves a comprehensive approach that combines medical treatments such as oral medications and Botox injections with daily self-care practices, including stretching, exercise, and ...

Muscle spasticity is a common and often debilitating consequence of spinal cord injury that can significantly affect mobility and quality of life. Spasticity is a condition in which muscles become ...

Merz Therapeutics to present 11 abstracts at ISPRM World Congress 2026, highlighting its commitment to improving outcomes for people living with movement disorders Updated analysis indicates that ...

Spasticity is a condition that causes muscle stiffness and affects a person’s ability to speak and move. A variety of different treatment options are available to help manage this condition.

Spasticity is a condition that causes your muscles to stiffen, tighten, and contract. It happens involuntarily, which means you don’t have control over it. Spasticity typically happens because of ...

Spasticity causes muscle tightness and stiffness due to conditions like spinal cord injury, stroke, multiple sclerosis (MS), cerebral palsy, or brain injury. This can make everyday activities like ...

Animal or in vitro studies, studies performed in pediatric populations, and studies reporting treatment with BoNT products other than onabotulinumtoxinA were excluded. The full-text publications of ...